Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLGX
1051
DELISTED
Corelogic, Inc.
CLGX
| $6.91M | 0.02% |
227,588
-373,849
| -62% | -$10.8M |
|
1052
News Corp Class B
NWS
$17.3B
| $6.91M | 0.02% |
395,700
-106,300
| -21% | -$1.79M |
|
1053
Boston Scientific
BSX
$69B
| $6.9M | 0.02% |
540,205
-954,200
| -64% | -$12.4M |
|
|
PRGX
1054
DELISTED
PRGX Global, Inc.
PRGX
| $6.9M | 0.02% |
1,079,300
+17,840
| +2% | +$115K |
|
1055
Tower Semiconductor
TSEM
$22.9B
| $6.86M | 0.02% |
755,151
+286,140
| +61% | +$2.55M |
|
1056
Kilroy Realty
KRC
$4.46B
| $6.84M | 0.02% |
+109,900
| New | +$6.64M |
|
|
EDE
1057
DELISTED
Empire District Electric
EDE
| $6.83M | 0.02% |
266,000
+86,100
| +48% | +$2.08M |
|
|
EGL
1058
DELISTED
Engility Holdings, Inc.
EGL
| $6.83M | 0.02% |
178,500
-120,547
| -40% | -$4.99M |
|
|
CBM
1059
DELISTED
Cambrex Corporation
CBM
| $6.79M | 0.02% |
328,200
-142,325
| -30% | -$2.89M |
|
|
PRA
1060
DELISTED
ProAssurance
PRA
| $6.78M | 0.02% |
152,600
-79,404
| -34% | -$3.55M |
|
1061
Embotelladora Andina Series B
AKO.B
$4.73B
| $6.76M | 0.02% |
298,746
-25,554
| -8% | -$608K |
|
1062
TriCo Bancshares
TCBK
$1.84B
| $6.75M | 0.02% |
291,900
+25,663
| +10% | +$609K |
|
1063
Elbit Systems
ESLT
$38.2B
| $6.72M | 0.02% |
109,200
-2,600
| -2% | -$159K |
|
|
RDC
1064
DELISTED
Rowan Companies Plc
RDC
| $6.69M | 0.02% |
209,400
+106,600
| +104% | +$3.34M |
|
|
AAIC
1065
DELISTED
Arlington Asset Investment Corp.
AAIC
| $6.68M | 0.02% |
244,592
+38,275
| +19% | +$1.03M |
|
1066
Insperity
NSP
$1.98B
| $6.68M | 0.02% |
405,000
+68,400
| +20% | +$1.09M |
|
|
ITC
1067
DELISTED
ITC HOLDINGS CORP
ITC
| $6.67M | 0.02% |
+182,800
| New | +$6.75M |
|
|
WPRT
1068
Westport Fuel Systems
WPRT
$32.9M
| $6.67M | 0.02% |
37,000
-7,850
| -18% | -$1.17M |
|
|
CIR
1069
DELISTED
CIRCOR International, Inc
CIR
| $6.67M | 0.02% |
+86,423
| New | +$6.68M |
|
1070
Northwest Bancshares
NWBI
$2.35B
| $6.66M | 0.02% |
490,554
-205,900
| -30% | -$2.83M |
|
1071
Insulet
PODD
$11.6B
| $6.63M | 0.02% |
167,200
-197,700
| -54% | -$7.6M |
|
|
SVA
1072
DELISTED
Sinovac Biotech, Ltd
SVA
| $6.63M | 0.02% |
1,175,000
+143,289
| +14% | +$870K |
|
1073
Kemper
KMPR
$1.83B
| $6.6M | 0.02% |
179,000
+35,369
| +25% | +$1.31M |
|
1074
Clearfield
CLFD
$419M
| $6.58M | 0.02% |
392,199
-43,000
| -10% | -$783K |
|
1075
Prologis
PLD
$138B
| $6.57M | 0.02% |
+159,771
| New | +$6.57M |
|
Similar funds
Renaissance Technologies's Q2 2014 Portfolio in Review
As of Q2 2014, Renaissance Technologies held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Renaissance Technologies added most to Pfizer in Q2 2014, an estimated $276M increase.
- Renaissance Technologies's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Renaissance Technologies fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Renaissance Technologies's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Renaissance Technologies opened 450 new positions and closed 492 in Q2 2014.
- Renaissance Technologies's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.